The Impact of Biomarkers on Clinical-Stage Biopharmaceutical Innovation
Biomarkers—biological molecules indicating specific physiological or pathological states—have revolutionized drug development and personalized medicine. In the fast-expanding biopharmaceutical research sector across the Asia-Pacific (APAC) region, biomarkers play a crucial role in optimizing clinical trials, improving patient outcomes, and accelerating the creation of innovative therapies.